Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease.
Publication
, Journal Article
Ong, SS; Doraiswamy, PM; Lad, EM
Published in: JAMA Neurol
June 1, 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Neurol
DOI
EISSN
2168-6157
Publication Date
June 1, 2018
Volume
75
Issue
6
Start / End Page
650 / 651
Location
United States
Related Subject Headings
- Retina
- Optic Nerve
- Humans
- Forecasting
- Biomarkers
- Alzheimer Disease
Citation
APA
Chicago
ICMJE
MLA
NLM
Ong, S. S., Doraiswamy, P. M., & Lad, E. M. (2018). Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease. JAMA Neurol, 75(6), 650–651. https://doi.org/10.1001/jamaneurol.2018.0602
Ong, Sally S., P Murali Doraiswamy, and Eleonora M. Lad. “Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease.” JAMA Neurol 75, no. 6 (June 1, 2018): 650–51. https://doi.org/10.1001/jamaneurol.2018.0602.
Ong SS, Doraiswamy PM, Lad EM. Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease. JAMA Neurol. 2018 Jun 1;75(6):650–1.
Ong, Sally S., et al. “Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease.” JAMA Neurol, vol. 75, no. 6, June 2018, pp. 650–51. Pubmed, doi:10.1001/jamaneurol.2018.0602.
Ong SS, Doraiswamy PM, Lad EM. Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease. JAMA Neurol. 2018 Jun 1;75(6):650–651.
Published In
JAMA Neurol
DOI
EISSN
2168-6157
Publication Date
June 1, 2018
Volume
75
Issue
6
Start / End Page
650 / 651
Location
United States
Related Subject Headings
- Retina
- Optic Nerve
- Humans
- Forecasting
- Biomarkers
- Alzheimer Disease